1998

Andersen SL, Oloo AJ, Gordon DM, Aleman G, Berman J, Tang DB, Dunne MW, Shanks GD. A double blinded, placebo controlled trial of azithromycin compared to doxyctckube for malaria prophylaxis in western Kenya. Clinical Inf Dis; 1998: 26: 146‑150.

Berman-JD; Badaro-R;Thakur-CP; Wasunna-KM; Behbehani-K; Davidson-R; Kuzoe-F; Pang-L; Weerasuriya-K; Bryceson-AD. (1998). Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. Bull-World-Health-Organ.76(1): 25-32.

Broadhurst LE, Kelly DJ, Chan C.T;, Smoak BL, Brundage JF, McClain JB, Miller RN. Laboratory evaluation of a dot blot enzyme immunoassay for serological confirmation of illness due to Rickettsia conorii. Am J Trop Med Hyg 1998; 58:786-9

Edstein MD, Bahr S, Kotecka, B, Shanks GD, Rieckmann KH. In vitro activity of the biguanide, PS-15, and its metabolite, WR99210 against cycloguanil, resistant Plasmodium falciparum isolates from Thailand. Ant micro Agents Chemo 1998; 41:2300-01.

Fried-M; Duffy-PE. (1998 Mar). Maternal malaria and parasite adhesion. J- Mol-Med. 76(3-4): 162-71

Fried-m; Muga-RO; Misore-RO; Duffy-PE.(1998Mar1). Malaria elicits type1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. J-Immunol.160(5):2523-30  

Fried-M; Nosten-F; Brockman-A; Brabin-BJ; Duffy-PE, (1998).  Maternal antibodies block malaria.  Nature, Vol. 395.

Gambel JM, Brundage JF, Burge RJ, DeFraites RF, Smoak BL, Wirtz RA. Survey of US Army soldiers' knowledge, attitudes, and practices regarding personal protection measures to prevent arthropod-related diseases and nuisance bites. Mil Med in press

Garcia GE, Wirtz RA, Barr JR, Woolfit A & Rosenberg R (1998). Xanthurenic acid induces gametogenesis in Plasmodium, the malaria parasite. Journal of Biological Chemistry, 273: 12003-12005.

Iversen-ER;Colding-H;Peterson-L; Ngetich-R;Shanks-GD.(1998Jan-Feb).Epidemic Shigella dysenterae in Mumias,Western Kenya. TRANS-R-SOC-TROP-MED-HYG.92(1):30-1.  

J. A. Stoute et al. Long Term Efficacy and Immune Responses Following Immunization with the RTS,S Malaria Vaccine. J Infect Dis 178(4):1139-1144, 1998.

José A. Stoute and W. Ripley Ballou. Malaria Vaccines: Current Status. BioDrugs. 10(2):123-136, 1998.

Kanesa, thasan N, Chang G-J J, Smoak BL, Magill A, Burrous MJ, Hoke CH. Molecular and epiderniologic analysis of dengue virus isolates from Somalia. Emerging infectious Diseases 1998; 4: 299-303.

Kariuki-MM;Kiairia-JK;Mulaa-FK;Wasunna-KM;Martin-SK.(1998).Plasmodium Falcipurum: Purification of the variuos gametocyte developmental stages from in  vitro-cultivated parasite.Am-J-Trop-Med- Hyg. 59(4):505-508.

Kurtis-JD., Koros-JK, Duffy-PE; Green-MD. (1998 Apr 1). Malaria prevention for travelers [letter]. JAMA. 279(13): 990- 1.  

Luckhart S, Vodovotz Y, Cui L & Rosenberg R (1998). The mosquito Anopheles stephensi limits malaria parasite development with inducible synthesis of nitric oxide. Proc Natl Acad Sci USA, 95: 5700-5705.

Malakooti MA, Biomndo K, Shanks GD. Re-emergence of epidemic highland malaria in western Kenya. J Emerging Infect Dis 1998 4:(4).

Martin-SK; Thuita-Harun-L; Adoyo-Adoyo-M; Wasunna-KM. (1998). A diagnostic ELISA for visceral leishmania based on antigen from media conditioned by Leishmania donovani promastigotes. Annals of Tropical Medicine& Parasitolooy. 92(5)~ 571‑577.

Mason-CJ; Kitsiripornchai-S; Markowitz-LE, Chanbancherd-P, Supapongse-T, Jugsudee-A; Sirisopana-N; Chuenchitra-C; Torugsa-K, VanCott-TC, Michael-RA, Nitayaphan-S; (1998).  Nationwide surveillance of HIV-1 prevalence and subtype in young Thai men.  Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 19:165-173.  

Shanks- GD, Karwacki JJ, (1998). Malaria in Preventive Medicine: Mobilization and Deployment Textbook of Millitary Medicine Series (in press)

Shanks GD, Gordon DM, Klotz FW, Aleman GM, Oloo AJ, Sadie D, Scott TR. Efficacy and safety of atovaquone/proquanil for suppressive prophylaxis against plasmodium falcipurum Malaria. Clinical Infect Dis 1998(in press).

Smoak BL, et al. Centers for Disease Control and Prevention. Rift Valley Fever,  East Africa, 1997-1998. MMWR 1998; 47: 261-4.

Smoak-BL et al., (1998).  Rift Valley Fever - East Africa, 1997-1998.  Mobidity and Mortality Weekly Report,  47: 261-264.

Shanks GD.(1998). Possible options for malaria chemoprophylaxis on the horizon. Journal of Travel Medicine, Vol.6.S31

Waitumbi-j, Warburg-A (1998). Phlebotomus papatasi saliva inhibits protein phosphatase activity and nitric oxide production by murine macrophages. Infection and immunity, 1534-1537.

1999      top

Luckhart S; Rosenberg R. (1999).  Gene structure and polymorphism of an invertebrate nitric oxide synthesis     gene. , 232:25 34.

Mason-CJ; & Longfield-RN.  Nontyphoidal salmonella Infections Stirckland 6223-4 6223xx7601 04-07-99 16:04:23  Galley 1 Keyed by: APT.  

Ockenhouse-CF; Sun-PF; Lanar-DE; Wellde- BT; Hall-BT; Kester -K;Stoute-JA; Magill-A;Krzych-U; Farley-L;Wirtz-RA; Sadoff-JC; Kaslow-DC; Kumar-S;Church-LW; Crutcher-JM; Wizel-B; Hoffman-S;Lalvani-A; Hill-AV; Tine-J; Guito- KP;de-Taisne-C;Anders-R; Ballou-WR; et-al(1998). phase VIIa safety,immunologenicity and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for plasmodium falcipurum malaria.journal of Infectious Disease, 177(6): 1664-73.

Smoak BL; Sharp T; Guerrant RL; Krogstead DJ; Maguire JG; Walder DH; Weller PF; Churchill L. Millitary Populations in Tropical infectious diseases in principles pathogens and practice (Submitted).

Smoak BL; Petrucelli BP. Medicine threat assessment in preventive medicine: Mobilization  & Deployment in textbook of military medicine.

Smoak BL; Sharp T; Guerrant RL. Military Populations in Tropical infectious diseases for the clinician ( submitted).

Smoak BL; Sharp T: Tropical Infectious Diseases. Principles, Pathogens, and Practise Guarrant RL, Krogstead DL, Maguire,.

Shanks-GD, Ragama BO, Oloo AJ. (1999) Time to reappearance of malaria parasites following various drug treatment regimens in a holo-endemic area of western Kenya.  Transactions of the Royal Society of Tropical Medicine and Hygiene, 93: 304-305

Shanks-GD.  (1999).  New options for the prevention and treatment of malaria:  Focus on the role of Atovaquone and Proquanil Hydrochloride,  Journal of Travel Medicine.  Vol. 6. S1.  

Shanks GD; Biomndo K; Hay SL;Snow RW. Changing patterns of clinical malaria since 1965 among a tea plantation located in the Kenyan highlands. Transactions of Royal society of Tropical Medicine and Hygiene.

Shanks GD; Colgan M; Ochieng M; Biomndo k. Epidemiology of vaccine preventable diseases over 40 years on a tea plantation in western Kenya ( Submitted).

Shanks GD; Smoak BL; Aleman GD; Oundo J; Waiyaki PG; Dunne; MW; Petersen L and the acute dysentery study group(1999). Single dose of Azithromycine or three day course of ciprofloxacine as therapy for epidemic dysentery in Kenya. Clinical Infectious Diseases, 29:942-3.

2000             top

Burkot TR; Schneider BS; Pieniazek NJ; Happ CM; Rutherford JS; Slemenda SB; Hoffmeister E; Maupin GO; Zeidner NS. Babesi microti and Borellia bissettii transmission by lxodes spinipalpis ticks among prairie voles, Microtus ochrogaster, in Colorado. Parasitology. 2000 Dec, 121 pt 6:595-9.

Cui LS; Luckhart S; Rosenberg R.(2000). Molecular characterization of a prophenoloxidase cDNA from the malaria mosquito Anopheles stephensi. Insect Molecular BIOLOGY, 9(2): 127-137.

Hay SL; Myers MF;Burke DS;Vaughn DW; Endy T; Ananda N; Shanks GD; Snow RW; Rogers DJ.(2000). Etiology of interepidemic periods of mosquito borne disease. Proceedings of the National Academy of Sciences(USA), 97(16): 9335-9339.         

Ofulla AVO, Kiare F, Mwangi JK, Githure JI, Orago AS, Smoak B, Martin SK.  The use of a serum-free medium to transport Plasmodium falciparum isolates to a central laboratory for the determination of anti-malaria drug sensitivity.  American Journal of Tropical Medicine and Hygiene (Submitted).  

Ogutu BR; Smoak BL; Ngacha DAM; Nduati RW; Mwatha J; Shanks GD (2000). The efficacy of sulfadoxine/ pyrimethamine (fansider) in the treatment of uncomplicated plasmodium falciparum malaria in Kenya childdren. Transactions of Royal Society of Tropical Medicine and Hygiene, 94: 83-84.

Waitumbi JN; Opollo MO; Muga RO; Misore AO; Stoute JA(2000). Red cell surface changes and eyrthrophagocytosis in children with severe plasmodium falciparum anemia. Blood, Vol.95, Number 4.

Zeidner NS; Burkot TR; Massung R; Nicholson WL, Dolan MC; Rutherford JS; Biggerstaff BJ; Maupin GO. Transmission of the agent of human granulocytic ehrlichiosis by lxodes spinipalpis ticks evidence of an enzootic cycle of dual infection with Borrelia burgdorferi in Northen Colorado. J Infect Dis. 2000 Aug; 182 (2): 616-9.

PRESENTATIONS AT MARCH 2000 MEETING OF THE AMERICAN SOCIETY OF TROPICAL MEDICINE AND HYGIENE, HOUSTON, TEXAS.           top

Cumming JF; Stoute JA;Heppner DG;Kester KE; Gasser RA; Moran K;Shanks GD; Mason C; Prescott WR; Tang D; and Martin L. A critical Evaluation of exclusion/inclusion criteria for a randomized, double -blind, placebo controlled evaluation of weekly tafenoquine(WR 238605/SB 252263)Compared to Mefloquine for chemosuppression of Plasmodium Falcipurum in Western Kenya. 

Mbaisi A; Alam UH; Mwangi J; Cortese J; Smoak BL; Elson L and Mason CJ. DFHR and DHPS  Mutations in Plasmodium falciparum isolates from symptomatic individuals in southern Kenya. 

Kester KE; Stoute JA: Mason C; Siangla J; Opollo M; Vigneron L; Walter M; Heppner DG;Tornieporth N; Voss G;  Bellou WR; and Cohen. Safety and immunogenicity of the lyophilized RTS,S/SBAS2 Malaria vaccine in a malaria- experienced adult population of western Kenya.  

Shanks GD;Snow RW; GuyatiH; Arness m; Bradshaw D; Maguire J  and Biomndo K.Travel to malaria endemic areas as a factor in highland malaria in western Kenya. 

Sun PF; Schwenk R; Palmer D; Berenzon D; Stoute JA; Kester KE; Cohen J; Voss G; Ballou WR; Heppner DG; and Krzych U. T Lymphocytes responses induced by immunization with the candidate plasmodium falcipurum vaccine RTS, S/SBAS2.